Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, al ...
Analysts covering the sector have turned more constructive on cannabis stocks, citing improved regulatory clarity and ...
Venezuela's vast oil reserves and deteriorating infrastructure have suddenly become the centre of intense scrutiny by Wall Street, as global financiers evaluate what could be one of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback